Hyrimoz and Psoriasis aggravated - a phase IV clinical study of FDA data

Summary:

Psoriasis aggravated is reported as a side effect among people who take Hyrimoz (adalimumab-adaz), especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months also take Methotrexate, and have Psoriatic arthropathy.

The phase IV clinical study analyzes which people have Psoriasis aggravated when taking Hyrimoz. It is created by eHealthMe based on reports of 4,629 people who have side effects when taking Hyrimoz from the FDA, and is updated regularly.

What is Hyrimoz?

Hyrimoz has active ingredients of adalimumab-adaz. eHealthMe is studying from 4,635 Hyrimoz users. Check the latest studies of Hyrimoz.

What is Psoriasis aggravated?

Psoriasis aggravated (immune-mediated disease that affects the skin) is found to be associated with 1,293 drugs and 475 conditions by eHealthMe. Check the latest studies of Psoriasis aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 29, 2026

4,629 people reported to have side effects when taking Hyrimoz.
Among them, 138 people (2.98%) have Psoriasis aggravated.

Could Hyrimoz cause Psoriasis aggravated?

Among these 138 people:

How long have people been on Hyrimoz when they have Psoriasis aggravated? *

Click here to view more results

What is the gender of people who have Psoriasis aggravated when taking Hyrimoz? *

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Hyrimoz and have Psoriasis aggravated?

- Check whether Psoriasis aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hyrimoz:

Hyrimoz (4,635 reports)

Psoriasis aggravated treatments and more:

Psoriasis aggravated (396 reports)

How severe was Psoriasis aggravated and when was it recovered:

Psoriasis aggravated in Hyrimoz

Expand to all the drugs that have ingredients of adalimumab-adaz:

Psoriasis aggravated and drugs with ingredients of adalimumab-adaz

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Hyrimoz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Psoriasis aggravated:

Psoriasis aggravated (1,293 drugs)

Browse all the conditions that are associated with Psoriasis aggravated:

Psoriasis aggravated (475 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on adalimumab-adaz (the active ingredients of Hyrimoz) and Hyrimoz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.